← Dashboard
Oct 06, 2026 01:16 PM ET
Signal
FDA/Bio
Vaxcyte stock surged after its pneumococcal vaccine passed a key phase 3 test
Vaxcyte surged on positive phase 3 pneumococcal vaccine results.
What changed
Vaxcyte surged on positive phase 3 pneumococcal vaccine results.
Why it matters
Vaxcyte surged on positive phase 3 pneumococcal vaccine results. — impact context not separately stored; see What changed.
Sources
qz
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →